Published in Am J Hypertens on January 01, 1999
Gender-specific associations of short sleep duration with prevalent and incident hypertension: the Whitehall II Study. Hypertension (2007) 5.20
Cardiovascular, inflammatory, and metabolic consequences of sleep deprivation. Prog Cardiovasc Dis (2008) 3.17
Mortality associated with short sleep duration: The evidence, the possible mechanisms, and the future. Sleep Med Rev (2009) 2.69
Overtime work, insufficient sleep, and risk of non-fatal acute myocardial infarction in Japanese men. Occup Environ Med (2002) 2.43
Sleep quality and elevated blood pressure in adolescents. Circulation (2008) 2.08
Sleep duration and risk for hypertension in women: results from the nurses' health study. Am J Hypertens (2013) 2.03
Sleep: a health imperative. Sleep (2012) 2.01
Short sleep duration as an independent predictor of cardiovascular events in Japanese patients with hypertension. Arch Intern Med (2008) 2.00
Sleep duration associated with mortality in elderly, but not middle-aged, adults in a large US sample. Sleep (2008) 1.98
Problems associated with short sleep: bridging the gap between laboratory and epidemiological studies. Sleep Med Rev (2009) 1.97
Epidemiological evidence for the links between sleep, circadian rhythms and metabolism. Obes Rev (2009) 1.83
Gender differences in the cross-sectional relationships between sleep duration and markers of inflammation: Whitehall II study. Sleep (2009) 1.77
Sleep loss and inflammation. Best Pract Res Clin Endocrinol Metab (2010) 1.69
Resistant hypertension and obstructive sleep apnea in the setting of kidney disease. J Hypertens (2012) 1.49
Work stress, sleep deficiency, and predicted 10-year cardiometabolic risk in a female patient care worker population. Am J Ind Med (2014) 1.45
Environmental noise and sleep disturbances: A threat to health? Sleep Sci (2014) 1.44
The relationship of sleep duration and insomnia to risk of hypertension incidence: a meta-analysis of prospective cohort studies. Hypertens Res (2013) 1.27
Effects of massage therapy on sleep quality after coronary artery bypass graft surgery. Clinics (Sao Paulo) (2010) 1.21
Associations of early pregnancy sleep duration with trimester-specific blood pressures and hypertensive disorders in pregnancy. Sleep (2010) 1.14
Sleep duration as a risk factor for cardiovascular disease- a review of the recent literature. Curr Cardiol Rev (2010) 1.09
Sleep duration and ambulatory blood pressure in black and white adolescents. Hypertension (2012) 1.06
Increasing sleep duration to lower beat-to-beat blood pressure: a pilot study. J Sleep Res (2012) 1.02
Cardiovascular reactivity to acute psychological stress following sleep deprivation. Psychosom Med (2011) 1.01
Sympathetic neural responses to 24-hour sleep deprivation in humans: sex differences. Am J Physiol Heart Circ Physiol (2012) 1.01
The effect of 60-h sleep deprivation on cardiovascular regulation and body temperature. Eur J Appl Physiol (2008) 0.99
Circadian misalignment increases cardiovascular disease risk factors in humans. Proc Natl Acad Sci U S A (2016) 0.91
Partial sleep restriction activates immune response-related gene expression pathways: experimental and epidemiological studies in humans. PLoS One (2013) 0.89
Total sleep deprivation alters endothelial function in rats: a nonsympathetic mechanism. Sleep (2014) 0.87
A review of evidence for the link between sleep duration and hypertension. Am J Hypertens (2014) 0.86
Role of sleep quality in the metabolic syndrome. Diabetes Metab Syndr Obes (2016) 0.86
Vascular endothelial function and self-reported sleep. Am J Med Sci (2014) 0.80
The Association between Sleep Duration and Hypertension in Non-obese Premenopausal Women in Korea. Korean J Fam Med (2016) 0.80
Cumulative association of obstructive sleep apnea severity and short sleep duration with the risk for hypertension. PLoS One (2014) 0.79
Associations of short sleep duration with prehypertension and hypertension among Lithuanian children and adolescents: a cross-sectional study. BMC Public Health (2014) 0.79
Gender- and age-specific associations between sleep duration and prevalent hypertension in middle-aged and elderly Chinese: a cross-sectional study from CHARLS 2011-2012. BMJ Open (2016) 0.79
Sleep: important considerations for the prevention of cardiovascular disease. Curr Opin Cardiol (2016) 0.79
Siesta is associated with reduced systolic blood pressure level and decreased prevalence of hypertension in older adults. J Hum Hypertens (2015) 0.78
Relationship between Duration of Sleep and Hypertension in Adults: A Meta-Analysis. J Clin Sleep Med (2015) 0.78
The Risk of Developing Diabetes in Association With Long Working Hours Differs by Shift Work Schedules. J Epidemiol (2016) 0.77
Associations of a Short Sleep Duration, Insufficient Sleep, and Insomnia with Self-Rated Health among Nurses. PLoS One (2015) 0.77
Sleep Duration and Cardiovascular Disease Risk: Epidemiologic and Experimental Evidence. Sleep Med Clin (2016) 0.77
The complex relationship between CKD and ambulatory blood pressure patterns. Adv Chronic Kidney Dis (2015) 0.77
Disentangling the effects of insomnia and night work on cardiovascular diseases: a study in nursing professionals. Braz J Med Biol Res (2014) 0.77
Association between short sleep and body mass index, hypertension among acute coronary syndrome patients in coronary care unit. Glob J Health Sci (2014) 0.76
Lower ankle-brachial index is associated with poor sleep quality in patients with essential hypertension. Am J Cardiovasc Dis (2015) 0.76
Maternal sleep duration and complaints of vital exhaustion during pregnancy is associated with placental abruption. J Matern Fetal Neonatal Med (2014) 0.75
Sleep to lower elevated blood pressure: study protocol for a randomized controlled trial. Trials (2014) 0.75
Lifestyle-related factors that explain disaster-induced changes in socioeconomic status and poor subjective health: a cross-sectional study from the Fukushima health management survey. BMC Public Health (2017) 0.75
Age- and gender-specific associations between sleep duration and incident hypertension in a Chinese population: the Kailuan study. J Hum Hypertens (2016) 0.75
Testing for carryover effects after cessation of treatments: a design approach. BMC Med Res Methodol (2016) 0.75
Association between sleep disorders and hypertension in Taiwan: a nationwide population-based retrospective cohort study. J Hum Hypertens (2016) 0.75
The relationship between hypertension and sleep duration: an analysis of the fifth Korea National Health and Nutrition Examination Survey (KNHANES V-3). Clin Hypertens (2015) 0.75
Neural Consequences of Chronic Short Sleep: Reversible or Lasting? Front Neurol (2017) 0.75
Morning surge in blood pressure and sympathetic activity in Mongolians and Han Chinese: a multimodality investigation of hypertension and dyssomnia. PeerJ (2017) 0.75
Sleep-related movement disorders. Neurol Sci (2011) 0.75
Multicentre randomised phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced non-small cell lung cancer. Eur J Cancer (2005) 1.55
Effect of delapril-manidipine combination vs irbesartan-hydrochlorothiazide combination on fibrinolytic function in hypertensive patients with type II diabetes mellitus. J Hum Hypertens (2004) 1.44
Effects of a restricted sleep regimen on ambulatory blood pressure monitoring in normotensive subjects. Am J Hypertens (1996) 1.43
Comparative effects of ramipril and nitrendipine on albuminuria in hypertensive patients with non-insulin-dependent diabetes mellitus and impaired renal function. J Hum Hypertens (1995) 1.39
Autologous platelet transfusion in patients receiving high-dose chemotherapy and circulating progenitor cell transplantation for stage II/III breast cancer. Haematologica (1998) 1.39
Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer. Br J Cancer (2004) 1.20
The accuracy of magnetic resonance imaging and ultrasonography compared with surgical findings in the localization of the undescended testis. Arch Pediatr Adolesc Med (1994) 1.07
Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study. Am J Hypertens (2001) 1.07
Supportive care in patients with advanced non-small-cell lung cancer. Br J Cancer (2003) 1.04
Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Res (1999) 1.01
Influence of losartan and atenolol on memory function in very elderly hypertensive patients. J Hum Hypertens (2003) 0.98
Pharmacokinetics of VP16-213 given by different administration methods. Cancer Chemother Pharmacol (1982) 0.98
Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients. J Hum Hypertens (2007) 0.97
A combination of gemcitabine and 5-fluorouracil in advanced pancreatic cancer, a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD). Br J Cancer (1999) 0.95
Occupational noise exposure and blood pressure. J Hypertens (1994) 0.94
Sexual function in hypertensive males treated with lisinopril or atenolol: a cross-over study. Am J Hypertens (1998) 0.94
Efficacy and safety comparative evaluation of orlistat and sibutramine treatment in hypertensive obese patients. Diabetes Obes Metab (2005) 0.94
ACE inhibition but not angiotensin II antagonism reduces plasma fibrinogen and insulin resistance in overweight hypertensive patients. J Cardiovasc Pharmacol (1998) 0.93
Transient blindness and seizure associated with cisplatin therapy. J Cancer Res Clin Oncol (1988) 0.93
Calcium channel blockade and cardiovascular prognosis in the European trial on isolated systolic hypertension. Hypertension (1998) 0.92
Effects of different dihydropyridine calcium antagonists on plasma norepinephrine in essential hypertension. J Hypertens (2000) 0.92
Metabolic variations with oral antidiabetic drugs in patients with Type 2 diabetes: comparison between glimepiride and metformin. Diabetes Nutr Metab (2004) 0.92
Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: a comparative study of the efficacy and safety against amlodipine. Clin Pharmacol Ther (1996) 0.92
Effect of telmisartan/hydrochlorothiazide vs lisinopril/hydrochlorothiazide combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients. J Hum Hypertens (2006) 0.92
Hypothalamic-pituitary dysfunction in growth hormone-deficient patients with pituitary abnormalities. J Clin Endocrinol Metab (1991) 0.92
Ambulatory blood pressure monitoring in normotensive and hypertensive type 2 diabetes. Prevalence of impaired diurnal blood pressure patterns. Am J Hypertens (1993) 0.91
Effects of nifedipine and indomethacin on cough induced by angiotensin-converting enzyme inhibitors: a double-blind, randomized, cross-over study. J Cardiovasc Pharmacol (1992) 0.90
Cardiovascular effects of melatonin in hypertensive patients well controlled by nifedipine: a 24-hour study. Br J Clin Pharmacol (2000) 0.90
Gemcitabine plus vinorelbine in advanced non-small cell lung cancer: a phase II study of three different doses. Gem Vin Investigators. Br J Cancer (2000) 0.89
Comparative effects of nebivolol and atenolol on blood pressure and insulin sensitivity in hypertensive subjects with type II diabetes. J Hum Hypertens (1997) 0.89
Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone. J Clin Pharm Ther (2007) 0.89
Diagnosing growth hormone deficiency: the value of short-term hypocaloric diet. J Clin Endocrinol Metab (1993) 0.87
Multicenter randomized clinical trial on high-dose epirubicin plus cis-platinum versus vinorelbine plus cis-platinum in advanced non small cell lung cancer. Lung Cancer (1998) 0.87
Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared with placebo and enalapril. J Hypertens (1996) 0.86
Pharmacokinetic studies in lung cancer patients. Cancer (1984) 0.86
Comparative effects of celiprolol, propranolol, oxprenolol, and atenolol on respiratory function in hypertensive patients with chronic obstructive lung disease. Cardiovasc Drugs Ther (1990) 0.86
Beta-blocker effects on plasma lipids during prolonged treatment of hypertensive patients with hypercholesterolemia. J Cardiovasc Pharmacol (1999) 0.85
Transient but not sustained blood pressure increments by occupational noise. An ambulatory blood pressure measurement study. J Hypertens (2001) 0.84
Cigarette smoking and blood pressure in a worker population: a cross-sectional study. J Cardiovasc Risk (1996) 0.84
Effects of different beta-blockers on lipid metabolism in chronic therapy of hypertension. Int J Clin Pharmacol Ther Toxicol (1988) 0.83
Different effects of aliskiren and losartan on fibrinolysis and insulin sensitivity in hypertensive patients with metabolic syndrome. Horm Metab Res (2010) 0.82
Half-strength atenolol-chlorthalidone combination (tenoretic mite) in the treatment of elderly hypertensive patients. Int J Clin Pharmacol Ther Toxicol (1984) 0.81
Comparison of metabolic effects of orlistat and sibutramine treatment in Type 2 diabetic obese patients. Diabetes Nutr Metab (2004) 0.81
Protein content and factor VIII complex in untreated, treated and monoclonal factor VIII concentrates. Thromb Res (1989) 0.81
Evaluation of emerging biomarkers in cardiovascular risk stratification of hypertensive patients: a 2-year study. Curr Med Res Opin (2012) 0.81
Familial AL-amyloidosis in three Italian siblings. Haematologica (1996) 0.81
Differential effects of ACE-inhibition and angiotensin II antagonism on fibrinolysis and insulin sensitivity in hypertensive postmenopausal women. Am J Hypertens (2001) 0.81
Comparative effects of lisinopril and losartan on insulin sensitivity in the treatment of non diabetic hypertensive patients. Br J Clin Pharmacol (1998) 0.81
A multicenter, randomized double-blind study of valsartan/hydrochlorothiazide combination versus amlodipine in patients with mild to moderate hypertension. J Hypertens (2001) 0.80
Long-term effects of ramipril and nitrendipine on albuminuria in hypertensive patients with type II diabetes and impaired renal function. J Hum Hypertens (1999) 0.80
Hydrochlorothiazide added to valsartan is more effective than when added to olmesartan in reducing blood pressure in moderately hypertensive patients inadequately controlled by monotherapy. Adv Ther (2006) 0.80
Effect of low-dose manidipine on ambulatory blood pressure in very elderly hypertensives. Cardiovasc Drugs Ther (1999) 0.80
Efficacy and safety of a musically modulated electromagnetic field (TAMMEF) in patients affected by knee osteoarthritis. Clin Exp Rheumatol (2004) 0.79
Schedule specific biochemical modulation of 5-fluorouracil in advanced colorectal cancer: a randomized study. GISCAD, IOR and collaborating centers. Ann Oncol (2000) 0.79
A study on the anisole-water complex by molecular beam-electronic spectroscopy and molecular mechanics calculations. J Chem Phys (2004) 0.79
Community control of hypertension at work-site: epidemiological data of the Agusta project. Eur J Epidemiol (1995) 0.79
Evaluation of nocturnal blood pressure by the Multi-P Analysis of 24-hour ambulatory monitoring. Z Kardiol (1996) 0.79
Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients. Br J Clin Pharmacol (1995) 0.79
Comparative effects of telmisartan and eprosartan on insulin sensitivity in the treatment of overweight hypertensive patients. Horm Metab Res (2009) 0.79
Losartan and amlodipine on myocardial structure and function: a prospective, randomized, clinical trial. Diabet Med (2012) 0.79
Combined therapy with benazepril and amlodipine in the treatment of hypertension inadequately controlled by an ACE inhibitor alone. J Cardiovasc Pharmacol (1997) 0.79
Efficacy and tolerability of manidipine hydrochloride in the long-term treatment of mild-moderate hypertension. Manidipine Efficacy in Long-Term Treatment Group. Blood Press Suppl (1996) 0.79
Epirubicin versus mitoxantrone in combination chemotherapy for metastatic breast cancer. Anticancer Res (1995) 0.79
Effects of lisinopril vs hydralazine on left ventricular hypertrophy and ambulatory blood pressure monitoring in essential hypertension. Eur Heart J (1995) 0.78
Early phase pharmacokinetics of doxorubicin (adriamycin) in plasma of cancer patients during single- or multiple-drug therapy. Cancer Treat Rep (1981) 0.78
Double-blind clinical assessment of alprazolam, a new benzodiazepine derivative, in the treatment of moderate to severe anxiety. J Clin Pharmacol (1981) 0.78
Measuring severity and change in anorexia nervosa. Adolescence (1983) 0.78
Double-blind comparison of the cardioselective beta-blockers bisoprolol and atenolol in hypertension: the Bisoprolol International Multicenter Study (BIMS). J Cardiovasc Pharmacol (1986) 0.78
Plasma and tissue distribution of adriamycin in patients with pelvic cancer. Tumori (1981) 0.78
Topographic variations of the skin impedence in the normal young adults. Boll Soc Ital Biol Sper (1982) 0.77
Combination chemotherapy with cyclophosphamide, fluorouracil, and either epirubicin or mitoxantrone: a comparative randomized multicenter study in metastatic breast carcinoma. Cancer Invest (1991) 0.77
Effect of benazepril addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients. J Hum Hypertens (2003) 0.77
Prospective phase II study of single-agent gemcitabine in untreated elderly patients with stage IIIB/IV non-small-cell lung cancer. Am J Clin Oncol (2001) 0.77
Reproducibility and clinical value of the trough-to-peak ratio of the antihypertensive effect: evidence from the sample study. Hypertension (1998) 0.77